Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On Syneos Health, Inc. (SYNH)

A market correction in the fourth quarter, spurred by a number of global macroeconomic concerns and rising interest rates ended up having a negative impact on the markets and many hedge funds as a result. The stocks of smaller companies were especially hard hit during this time as investors fled to investments seen as being safer. This is evident in the fact that the Russell 2000 ETF underperformed the S&P 500 ETF by 4 percentage points during the first half of the fourth quarter. We also received indications that hedge funds were trimming their positions amid the market volatility and uncertainty, and given their greater inclination towards smaller cap stocks than other investors, it follows that a stronger sell-off occurred in those stocks. Let’s study the hedge fund sentiment to see how those concerns affected their ownership of Syneos Health, Inc. (NASDAQ:SYNH) during the quarter.

Syneos Health, Inc. (NASDAQ:SYNH) shareholders have witnessed an increase in support from the world’s most elite money managers recently. SYNH was in 27 hedge funds’ portfolios at the end of the third quarter of 2018. There were 19 hedge funds in our database with SYNH positions at the end of the previous quarter. Our calculations also showed that synh isn’t among the 30 most popular stocks among hedge funds.

Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ large-cap stock picks indeed failed to beat the market between 1999 and 2016. However, we were able to identify in advance a select group of hedge fund holdings that outperformed the market by 18 percentage points since May 2014 through December 3, 2018 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that’ll significantly underperform the market. We have been tracking and sharing the list of these stocks since February 2017 and they lost 24% through December 3, 2018. That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.

Jeffrey Talpins Element Capital

Let’s review the key hedge fund action surrounding Syneos Health, Inc. (NASDAQ:SYNH).

How have hedgies been trading Syneos Health, Inc. (NASDAQ:SYNH)?

At Q3’s end, a total of 27 of the hedge funds tracked by Insider Monkey were long this stock, a change of 42% from one quarter earlier. The graph below displays the number of hedge funds with bullish position in SYNH over the last 13 quarters. With the smart money’s sentiment swirling, there exists a few key hedge fund managers who were increasing their holdings substantially (or already accumulated large positions).

No of Hedge Funds with SYNH Positions

When looking at the institutional investors followed by Insider Monkey, Viking Global, managed by Andreas Halvorsen, holds the number one position in Syneos Health, Inc. (NASDAQ:SYNH). Viking Global has a $93 million position in the stock, comprising 0.5% of its 13F portfolio. The second largest stake is held by Millennium Management, led by Israel Englander, holding a $66.8 million position; 0.1% of its 13F portfolio is allocated to the company. Some other members of the smart money with similar optimism encompass Amit Nitin Doshi’s Harbor Spring Capital, Jeffrey Talpins’s Element Capital Management and Amy Minella’s Cardinal Capital.

Now, specific money managers have been driving this bullishness. Element Capital Management, managed by Jeffrey Talpins, established the biggest position in Syneos Health, Inc. (NASDAQ:SYNH). Element Capital Management had $33.4 million invested in the company at the end of the quarter. Alec Litowitz and Ross Laser’s Magnetar Capital also made a $7.6 million investment in the stock during the quarter. The other funds with new positions in the stock are Noam Gottesman’s GLG Partners, John Brennan’s Sirios Capital Management, and Paul Marshall and Ian Wace’s Marshall Wace LLP.

Let’s go over hedge fund activity in other stocks – not necessarily in the same industry as Syneos Health, Inc. (NASDAQ:SYNH) but similarly valued. These stocks are Brighthouse Financial, Inc. (NASDAQ:BHF), Brixmor Property Group Inc (NYSE:BRX), CubeSmart (NYSE:CUBE), and The Dun & Bradstreet Corporation (NYSE:DNB). This group of stocks’ market values are similar to SYNH’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
BHF 22 1055138 -6
BRX 18 291321 1
CUBE 20 448124 1
DNB 34 792527 10
Average 23.5 646778 1.5

View table here if you experience formatting issues.

As you can see these stocks had an average of 23.5 hedge funds with bullish positions and the average amount invested in these stocks was $647 million. That figure was $414 million in SYNH’s case. Dun & Bradstreet Corporation (NYSE:DNB) is the most popular stock in this table. On the other hand Brixmor Property Group Inc (NYSE:BRX) is the least popular one with only 18 bullish hedge fund positions. Syneos Health, Inc. (NASDAQ:SYNH) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. In this regard DNB might be a better candidate to consider a long position.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...